Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3543 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Conditions: Primary Non-metastatic Breast Cancer;   Who Remain Disease-free
Interventions: Drug: Everolimus;   Drug: Placebo
22 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens
23 Unknown  Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Drug: aromatase inhibition therapy;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
24 Active, not recruiting Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Conditions: Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Drug: Exemestane
25 Recruiting Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women
Condition: Breast Cancer
Intervention: Other: Neuropsychological test battery
26 Active, not recruiting Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Letrozole
27 Recruiting A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy
Condition: Breast Cancer
Intervention: Behavioral: Individualized, tailored follow-up program
28 Terminated Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Acupuncture;   Procedure: Sham acupuncture therapy
29 Terminated Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Conditions: Breast Cancer;   Cancer of the Breast;   Neoplasms, Breast
Interventions: Drug: Estrace;   Drug: Anastrozole
30 Completed Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Conditions: Atherosclerosis;   Chlamydia Infections;   Cytomegalovirus Infections;   Pneumonia, Bacterial;   Postmenopause
Intervention: Drug: Estrogen therapy
31 Completed Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
Condition: Breast Cancer
Intervention: Other: survey administration
32 Completed Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Conditions: Postmenopausal Vasomotor Symptoms;   Cardiovascular Disease
Interventions: Drug: 17-b-estradiol;   Drug: 17-b-estradiol + medroxyprogeterone acetate;   Drug: 17-b-estradiol hemihydrate;   Drug: placebo pill + gel
33 Withdrawn Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: exemestane;   Procedure: adjuvant therapy;   Procedure: aromatase inhibition;   Procedure: conventional surgery;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: neoadjuvant therapy;   Procedure: surgery
34 Completed
Has Results
Early Menopause Hormone Treatment and Cognition
Condition: Menopausal Syndrome
Interventions: Drug: Estradiol (E2);   Drug: Progesterone (P10) x90;   Drug: Progesterone (P10) x10
35 Completed Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Condition: Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: ethinyl estradiol;   Drug: norgestrel;   Other: laboratory biomarker analysis
36 Active, not recruiting Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
Condition: Dementia
37 Completed The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
Conditions: Neoadjuvant Therapy;   Chemotherapy;   Hormone Replacement Therapy;   Breast Cancer
38 Recruiting Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Condition: Female Breast Cancer
Intervention: Drug: Toremifene; Anastrozole
39 Completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: tamoxifen citrate;   Drug: toremifene
40 Recruiting Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Condition: Advanced, Persistent, or Recurrent Endometrial Cancer
Interventions: Drug: Everolimus;   Drug: Tamoxifen;   Drug: Letrozole;   Drug: Medroxyprogesterone Acetate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years